Mozarc Medical Brand Guidelines: The 2023 Medtronic and DaVita Kidney-Tech Company

A medtech unit becomes a company.

Mozarc Medical is a young company with an old core. It was launched on 1 April 2023 by Medtronic and DaVita, according to a joint announcement datelined Dublin and Denver; Medtronic plc is headquartered in Dublin, Ireland, the release said. The release described it as “an independent new company committed to reshaping kidney health.” The two companies had signed the agreement to form it in May 2022, NS Medical Devices reported.

The new company was not built from scratch. Its global workforce, the announcement said, includes the former Medtronic Renal Care Solutions business, which became part of Mozarc Medical, together with staff hired for the new venture, and the former Renal Care Solutions leadership team moved across to lead it. Its chief executive is Ven Manda, described in the release as a 28-year veteran of Medtronic; Mozarc’s website still lists him as chief executive.

Ownership is split evenly. Under the terms of the agreement, Mozarc Medical is co-owned by Medtronic and DaVita, “each with equal equity stakes,” the announcement said, and NS Medical Devices reported the same. The pairing is unusual: Medtronic is a maker of medical devices, while DaVita is one of the largest providers of kidney-care services in the United States, as its own description in the release puts it. At the launch, DaVita’s head of research and development said the venture sought to change the approach to home dialysis through accessibility, ease of use and clinical performance — an aim, not a result.

From access through treatment.

Mozarc describes its range as “complete kidney solutions, from access through treatment.” Its product pages group the portfolio into three families: dialysis access and maintenance, chronic dialysis therapies and acute extracorporeal blood treatment therapies. For Europe, the Middle East and Africa it lists chronic haemodialysis systems and consumables, with work across therapy delivery, membranes, and liquids and concentrates, and it notes that products may not be available in every country.

One named system stands out on its US pages. The Carpediem system — its full name is “cardio renal pediatric dialysis emergency machine” — provides continuous renal replacement therapy for children weighing 2.5 to 10 kilograms, the company says, and it describes the machine as a miniaturised, high-precision platform designed specifically for small patients rather than adapted from adult equipment. Mozarc’s site credits the Covidien and Medtronic trademarks it uses as being used under licence from Medtronic, a reminder of where much of the range came from.

The company is spread across four regions. Its website gives regional headquarters in Minneapolis for the Americas, at a Medtronic Parkway address; in Mirandola, in Italy’s Modena province, for Europe, the Middle East and Africa; in Tokyo for Asia-Pacific; and in Shanghai for Greater China. Its leadership page lists regional heads for the Americas, Asia-Pacific, the EMEA region and Greater China, alongside global functions for product development, supply chain and marketing. The legal holder named on the website is Mozarc Medical Holding LLC. Separate product and support sections serve the United States, Europe, the Middle East and Africa, Japan and Mexico, with a support section for Greater China.

How kidney-care companies present themselves.

Dialysis and kidney-care companies sell to two audiences at once. One is clinical: nephrologists, nurses, technicians and hospital buyers who choose machines, dialyzers and solutions. The other is the patient, who may spend several sessions a week in a treatment chair or carry out dialysis at home. Their imagery tends to answer both: a calm patient in a reclining chair beside a machine, a nurse in a bright, orderly clinic, and close-ups of dialyzers, tubing and the screens of haemodialysis machines.

Home treatment has added a second setting. Peritoneal dialysis and home haemodialysis bring the equipment into kitchens, bedrooms and living rooms, and the companies that make or support it often show machines beside sofas and tables rather than in clinical rooms. Symbols tend to stay simple: kidney shapes, drops, waves and circles that print clearly on a label, a machine housing or a clinic sign.

The trade meets at a few large congresses. The American Society of Nephrology’s Kidney Week, held in Denver in 2026, drew nearly 12,000 participants from close to 100 countries, the society says, and makers such as Fresenius Medical Care list it among their events. In Europe, the European Renal Association holds an annual congress, scheduled for Rotterdam in 2027 and Berlin in 2028, according to the association.

This guide sets out what can be checked about each company: who founded it, who owns it, where it works and what it makes. Where a fact rests only on a company’s own word, we say so, and the colours and typefaces shown are our own interpretation rather than any official brand standard.

Empowering Patients. Enriching Lives.

As a brand, Mozarc had to be invented in one step. Its website carries the line “Empowering Patients. Enriching Lives.” as a trademark, and opens with the phrase “Kidney technology, transformed.” Its stated mission is to be “singularly focused on enriching lives by reshaping all aspects of kidney health with patient-centered technology solutions,” and it lists six core values, beginning with “Put patients and quality first” and continuing with “Take ownership,” “Invest in people,” “Cherish diversity,” “Be curious and creative” and “Lead with integrity and honesty.” Beside the products, the website promises providers ongoing education, training and assistance, under the heading “Unwavering support. Extensive resources.”

The parents stay visible. Every page of the website ends with the line “Mozarc Medical is a DaVita | Medtronic company,” and its about page says it is “supported by an investment between Medtronic, Inc. and DaVita Inc.” while calling itself independent. The new name carries neither parent’s word, so the endorsement line does the work of explaining where the company came from; the site is offered in seven languages, among them Chinese and Japanese.

For a designer the lesson is in that balance: a fresh name and a fresh promise for a business whose products, staff and much of its range came from an established medtech group. The company’s copy speaks of patients, caregivers and clinicians rather than of machines, and its product pages are organised by therapy stage — access, chronic care and acute care — rather than by device names.

For a design guide, Mozarc Medical shows how a carve-out can launch with its own name while still signing off with both parents. Compare Medtronic, the device group whose renal unit it absorbed, and DaVita, its kidney-care co-owner. For this guide we use a deep violet, an ink plum and a pale lilac with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Mozarc Medical’s identity on hand — save it to a board in the Made Good inspiration library.